Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
新型 SARS-CoV-2 β 变体受体结合域重组蛋白和 mRNA 疫苗作为第 4 剂加强剂的 I 期随机、安慰剂对照试验的中期结果
期刊:EBioMedicine
影响因子:9.7
doi:10.1016/j.ebiom.2023.104878
Terry M Nolan, Georgia Deliyannis, Maryanne Griffith, Sabine Braat, Lilith F Allen, Jennifer Audsley, Amy W Chung, Marcin Ciula, Nicholas A Gherardin, Michelle L Giles, Tom P Gordon, Samantha L Grimley, Lana Horng, David C Jackson, Jennifer A Juno, Katherine Kedzierska, Stephen J Kent, Sharon R Lewi